Nanoformulated fingolimod for spinal cord injury: promising anti‑neuroinflammatory effects but unsubstantiated bioavailability claims
Jasur RizaevDepartment of Public Health and Healthcare Management, Samarkand State Medical University, Samarkand, UzbekistanZ.K. RakhimovDepartment of Surgical Dentistry, Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, UzbekistanShadjalilova MukarramDepartment of Anatomy, Tashkent State Medical Institute, Tashkent, UzbekistanNilufar AkhmedovaDepartment of Obstetrics and Gynecology, Andijan State Medical Institute, Andijan, UzbekistanAkramova GulhayoBukhara State Medical Institute named after Abu Ali ibn SinoJavdat LatipovDepartment of Medicine, Termez University of Economics and Service, Termez, UzbekistanArman Abroumand GholamiNervous System Stem Cell Research Center, Semnan University of Medical Sciences, Semnan, Iran. [email protected]
2026en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 0Использованных источников: 7